| Product Code: ETC11721967 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Diabetic Neuropathy Management Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Diabetic Neuropathy Management Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Diabetic Neuropathy Management Market - Industry Life Cycle |
3.4 Israel Diabetic Neuropathy Management Market - Porter's Five Forces |
3.5 Israel Diabetic Neuropathy Management Market Revenues & Volume Share, By Device, 2021 & 2031F |
3.6 Israel Diabetic Neuropathy Management Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Diabetic Neuropathy Management Market Revenues & Volume Share, By End use, 2021 & 2031F |
3.8 Israel Diabetic Neuropathy Management Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.9 Israel Diabetic Neuropathy Management Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
4 Israel Diabetic Neuropathy Management Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Israel |
4.2.2 Growing awareness about diabetic neuropathy and its management |
4.2.3 Technological advancements in diabetic neuropathy treatment options |
4.3 Market Restraints |
4.3.1 High treatment costs associated with diabetic neuropathy management |
4.3.2 Limited access to specialized healthcare services in certain regions of Israel |
4.3.3 Lack of reimbursement policies for certain diabetic neuropathy treatments |
5 Israel Diabetic Neuropathy Management Market Trends |
6 Israel Diabetic Neuropathy Management Market, By Types |
6.1 Israel Diabetic Neuropathy Management Market, By Device |
6.1.1 Overview and Analysis |
6.1.2 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Device, 2021 - 2031F |
6.1.3 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Electrical Stimulation Devices, 2021 - 2031F |
6.1.4 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Neuro Stimulation Devices, 2021 - 2031F |
6.1.5 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Nerve Conduction Testing Devices, 2021 - 2031F |
6.1.6 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Other Devices, 2021 - 2031F |
6.2 Israel Diabetic Neuropathy Management Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Peripheral Neuropathy, 2021 - 2031F |
6.2.3 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Autonomic Neuropathy, 2021 - 2031F |
6.2.4 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Proximal Neuropathy, 2021 - 2031F |
6.2.5 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Mononeuropathy , 2021 - 2031F |
6.3 Israel Diabetic Neuropathy Management Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Home Healthcare, 2021 - 2031F |
6.3.4 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Other End Use, 2021 - 2031F |
6.4 Israel Diabetic Neuropathy Management Market, By Disease Type |
6.4.1 Overview and Analysis |
6.4.2 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Peripheral, 2021 - 2031F |
6.4.3 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Autonomic, 2021 - 2031F |
6.4.4 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Proximal, 2021 - 2031F |
6.4.5 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Focal, 2021 - 2031F |
6.5 Israel Diabetic Neuropathy Management Market, By Drug Class |
6.5.1 Overview and Analysis |
6.5.2 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Non-steroidal Anti-Inflammatory Drugs, 2021 - 2031F |
6.5.3 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Opioid, 2021 - 2031F |
6.5.4 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Anti-Depressants, 2021 - 2031F |
6.5.5 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Anti-Seizure, 2021 - 2031F |
6.5.6 Israel Diabetic Neuropathy Management Market Revenues & Volume, By Others, 2021 - 2031F |
7 Israel Diabetic Neuropathy Management Market Import-Export Trade Statistics |
7.1 Israel Diabetic Neuropathy Management Market Export to Major Countries |
7.2 Israel Diabetic Neuropathy Management Market Imports from Major Countries |
8 Israel Diabetic Neuropathy Management Market Key Performance Indicators |
8.1 Patient satisfaction with diabetic neuropathy management services |
8.2 Number of healthcare professionals trained in diabetic neuropathy management |
8.3 Adoption rate of new diabetic neuropathy treatment technologies |
8.4 Average time taken for diagnosis and initiation of diabetic neuropathy treatment |
8.5 Percentage of diabetic patients receiving regular neuropathy screenings |
9 Israel Diabetic Neuropathy Management Market - Opportunity Assessment |
9.1 Israel Diabetic Neuropathy Management Market Opportunity Assessment, By Device, 2021 & 2031F |
9.2 Israel Diabetic Neuropathy Management Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Diabetic Neuropathy Management Market Opportunity Assessment, By End use, 2021 & 2031F |
9.4 Israel Diabetic Neuropathy Management Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.5 Israel Diabetic Neuropathy Management Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10 Israel Diabetic Neuropathy Management Market - Competitive Landscape |
10.1 Israel Diabetic Neuropathy Management Market Revenue Share, By Companies, 2024 |
10.2 Israel Diabetic Neuropathy Management Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here